Spots Global Cancer Trial Database for crohn's disease
Every month we try and update this database with for crohn's disease cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Tumor Necrosis Factor Decreases Vitamin D Dependant Calcium Absorption | NCT00427804 | Rheumatoid Arth... Crohn's Disease | calcitriol | 18 Years - 50 Years | Atlanta VA Medical Center | |
| Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's Disease | NCT02499783 | Crohn's Disease | adalimumab placebo | 18 Years - 70 Years | AbbVie | |
| The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a Antagonists | NCT00224562 | Rheumatoid Arth... Crohn's Disease Ankylosing Spon... Psoriasis | TNF-alpha antag... | 0 Years - | Assistance Publique - Hôpitaux de Paris | |
| Chromoendoscopy for Dysplasia Detection in Chronic Inflammatory Bowel Disease | NCT01505842 | Ulcerative Coli... Crohn's Colitis | Colonoscopy wit... Conventional wh... | 18 Years - | Karolinska University Hospital | |
| Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease | NCT00325078 | Chronic Granulo... Crohn'S-like IB... Inflammatory Bo... | Infliximab | 10 Years - | National Institutes of Health Clinical Center (CC) | |
| Anti-Tumor Necrosis Factor (TNF) Treatments, Work Productivity and Quality of Life in Crohn's Disease | NCT01860846 | Crohn's Disease | 18 Years - 65 Years | AbbVie | ||
| Anti-Tumor Necrosis Factor (TNF) Treatments, Work Productivity and Quality of Life in Crohn's Disease | NCT01860846 | Crohn's Disease | 18 Years - 65 Years | AbbVie | ||
| Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients | NCT03452501 | Inflammatory Bo... Crohn Disease Fistulizing Cro... Ulcerative Coli... | Infliximab | 18 Years - | Hikma Pharmaceuticals LLC | |
| Mucosal Healing Study in Crohn's Disease (CD) | NCT00297648 | Crohn's Disease | Certolizumab pe... | 18 Years - | UCB Pharma | |
| Pre-treatment With Azithromycin to Reduce Immunogenicity to to Anti-TNF Agents in Patients With Crohn's Disease | NCT05599347 | Crohn's Disease... Biological Subs... | Azithromycin Pi... Placebo | 18 Years - | Rambam Health Care Campus | |
| Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease | NCT00222378 | Crohn's Disease Ulcerative Coli... | 18 Years - 70 Years | University of Miami | ||
| Study on Cannabinoid Receptor Expression in Gastrointestinal Diseases | NCT02735941 | Ulcerative Coli... Crohn's Disease Colon Cancer | 18 Years - | Medical University of Graz | ||
| OTIS Autoimmune Diseases in Pregnancy Project | NCT01086059 | Crohn's Disease Rheumatoid Arth... | - | University of California, San Diego | ||
| Intestinal Microbiota and Colorectal Cancer in Inflammatory Bowel Disease | NCT02726243 | Inflammatory Bo... Colorectal Canc... | 18 Years - | Assistance Publique - Hôpitaux de Paris | ||
| A Blood and Tissue Sample Collection Study of Patients Who Have Inflammatory Bowel Disease, Who Have Been Treated With Adalimumab and Who Developed Hepatosplenic T-Cell Lymphoma | NCT02087878 | Crohn's Disease Ulcerative Coli... Hepatosplenic T... | 1 Year - 99 Years | AbbVie | ||
| Safety of Anti-tumor Necrosis Factor (TNF) Monoclonal Antibodies in Inflammatory Bowel Disease | NCT02066272 | Inflammatory Bo... Ulcerative Coli... Crohn's Disease Indeterminate C... | - | Maria Sklodowska-Curie National Research Institute of Oncology | ||
| An Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy | NCT00467922 | Crohn's Disease Ulcerative Coli... Rectal Cancer Colon Cancer Colon Polyps Rectal Polyps Diverticulitis | Hextend Lactated Ringer... | 18 Years - 80 Years | Spectrum Health Hospitals | |
| Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease | NCT00004941 | Crohn's Disease | monoclonal anti... | 18 Years - 65 Years | FDA Office of Orphan Products Development | |
| Chromoendoscopy for Dysplasia Detection in Chronic Inflammatory Bowel Disease | NCT01505842 | Ulcerative Coli... Crohn's Colitis | Colonoscopy wit... Conventional wh... | 18 Years - | Karolinska University Hospital | |
| Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients | NCT03452501 | Inflammatory Bo... Crohn Disease Fistulizing Cro... Ulcerative Coli... | Infliximab | 18 Years - | Hikma Pharmaceuticals LLC | |
| Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients | NCT03452501 | Inflammatory Bo... Crohn Disease Fistulizing Cro... Ulcerative Coli... | Infliximab | 18 Years - | Hikma Pharmaceuticals LLC | |
| European Novel Motorized Spiral Endoscopy Trial | NCT02965209 | Disorder of Sma... Gastrointestina... Iron Deficiency... Crohn's Disease Small Bowel Tum... Intestinal Poly... Coeliac Disease | motorized spira... | 18 Years - | Evangelisches Krankenhaus Düsseldorf | |
| Value of Pharmacokinetic Assays in the Prediction of Induction and Maintenance Therapeutic Response in Crohn's Disease | NCT02768532 | Crohn Disease | Vedolizumab | 18 Years - | Centre Hospitalier Universitaire de Saint Etienne | |
| Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease | NCT02574637 | Crohn's Disease | Brazikumab IV I... Brazikumab SC I... Placebo | 18 Years - 80 Years | AstraZeneca | |
| Tumor Necrosis Factor Decreases Vitamin D Dependant Calcium Absorption | NCT00427804 | Rheumatoid Arth... Crohn's Disease | calcitriol | 18 Years - 50 Years | Atlanta VA Medical Center | |
| A Trial Evaluating Safety of Chronic Therapy With Certolizumab Pegol in Crohn's Disease | NCT00358683 | Crohn's Disease | Certolizumab pe... | 18 Years - | UCB Pharma | |
| Chromoendoscopy for Ulcerative Colitis Surveillance | NCT00274209 | Ulcerative Coli... Crohn's Disease | Chromoendoscopy... | 18 Years - | Indiana University | |
| Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease | NCT00552058 | Crohn Disease | certolizumab pe... Placebo | 18 Years - 75 Years | UCB Pharma | |
| General Surgical Outcomes Quality Improvement Database (UH-SOCRATES) | NCT00622557 | Colon Cancer Diverticulitis Colorectal Poly... Crohn's Disease Ulcerative Coli... Rectal Cancer | 14 Years - 95 Years | University Hospitals Cleveland Medical Center | ||
| Perfusion Assessment in Laparoscopic Left Anterior Resection | NCT01560377 | Rectal Cancer Colon Cancer Crohn's Disease Polyp Procidentia Diverticulitis | PINPOINT Endosc... | 18 Years - | Novadaq Technologies ULC, now a part of Stryker | |
| OTIS Autoimmune Diseases in Pregnancy Project | NCT01086059 | Crohn's Disease Rheumatoid Arth... | - | University of California, San Diego | ||
| Random Comparison of LigaSure and Disposable Staples for Laparoscopic Surgery | NCT00487409 | Colonic Disease... Rectal Diseases | Bipolar electro... Disposable stap... | 18 Years - 80 Years | University Hospitals Cleveland Medical Center | |
| Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease | NCT00552058 | Crohn Disease | certolizumab pe... Placebo | 18 Years - 75 Years | UCB Pharma | |
| An Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy | NCT00467922 | Crohn's Disease Ulcerative Coli... Rectal Cancer Colon Cancer Colon Polyps Rectal Polyps Diverticulitis | Hextend Lactated Ringer... | 18 Years - 80 Years | Spectrum Health Hospitals | |
| Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease. | NCT01714726 | Crohn's Disease | MEDI2070 placebo | 18 Years - 65 Years | AstraZeneca | |
| Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease | NCT00004941 | Crohn's Disease | monoclonal anti... | 18 Years - 65 Years | FDA Office of Orphan Products Development | |
| Tumor Necrosis Factor Decreases Vitamin D Dependant Calcium Absorption | NCT00427804 | Rheumatoid Arth... Crohn's Disease | calcitriol | 18 Years - 50 Years | Atlanta VA Medical Center | |
| Intestinal Microbiota and Colorectal Cancer in Inflammatory Bowel Disease | NCT02726243 | Inflammatory Bo... Colorectal Canc... | 18 Years - | Assistance Publique - Hôpitaux de Paris | ||
| Patient-Centred Innovations for Persons With Multimorbidity - Quebec | NCT02789800 | Hypertension Depression Anxiety Musculoskeletal... Arthritis Rheumatoid Arth... Osteoporosis Chronic Obstruc... Asthma Chronic Bronchi... Cardiovascular ... Heart Failure Stroke Transient Ische... Ulcer Gastroesophagea... Irritable Bowel Crohn's Disease Ulcerative Coli... Diverticulosis Chronic Hepatit... Diabetes Thyroid Disorde... Cancer Kidney Disease Urinary Tract P... Dementia Alzheimer's Dis... Hyperlipidemia HIV | DIMAC02 | 18 Years - 80 Years | Université de Sherbrooke | |
| Digestive Biobank for Exploring Microbiota-host Interactions | NCT05704413 | Inflammatory Bo... Crohn Disease Ulcerative Coli... Colorectal Canc... Indeterminate C... | 18 Years - | Assistance Publique - Hôpitaux de Paris | ||
| OTIS Autoimmune Diseases in Pregnancy Project | NCT01086059 | Crohn's Disease Rheumatoid Arth... | - | University of California, San Diego | ||
| Follow-up to Welcome Study C87042 [NCT00308581] Examining Certolizumab Pegol (CDP870) in Subjects With Crohn's Disease | NCT00333788 | Crohn's Disease | Certolizumab pe... | 18 Years - | UCB Pharma | |
| Safety of Anti-tumor Necrosis Factor (TNF) Monoclonal Antibodies in Inflammatory Bowel Disease | NCT02066272 | Inflammatory Bo... Ulcerative Coli... Crohn's Disease Indeterminate C... | - | Maria Sklodowska-Curie National Research Institute of Oncology | ||
| Anti-Tumor Necrosis Factor (TNF) Treatments, Work Productivity and Quality of Life in Crohn's Disease | NCT01860846 | Crohn's Disease | 18 Years - 65 Years | AbbVie | ||
| Digestive Biobank for Exploring Microbiota-host Interactions | NCT05704413 | Inflammatory Bo... Crohn Disease Ulcerative Coli... Colorectal Canc... Indeterminate C... | 18 Years - | Assistance Publique - Hôpitaux de Paris |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
